IDXX
US EQUITY
Health Care
Health Care Equipment
CIK: 874716
Idexx Laboratories (IDXX) Quant Factor Diagnostic & Fair Value Model
Idexx Laboratories (Ticker: IDXX) is listed in the Health Care sector (Health Care Equipment). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$560.38
-1.13%
Latest Close (2026-10-23)
Market Cap: $44.15B
P/E Ratio: 32.8
Momentum Strength
3M / 12M
+0.75%
1M: +9.15%
12M: -11.58%
Quality (ROE)
Point-in-Time
+83.94%
Trailing Return on Equity
Technical Trend
RSI 14
64.8
SMA50: $533.01
SMA200: $576.39
Valuation Multiplier
Trailing
32.8
Premium Multiple (> 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Premium Multiple (> 30x P/E)
IDXX trades at 32.8x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线整理 (MA20/50)
Piotroski F-Score: 6/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 874716 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-04 | $1.22B | $338.41M | $613.41M | $4.27 |
| 10-Q | 2026-03-31 | 2026-08-04 | $1.14B | $278.45M | $266.25M | $3.47 |
| 10-Q | 2025-12-31 | 2026-08-04 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-04 | $1.11B | $293.99M | $423.70M | $3.63 |
| 10-Q | 2025-03-31 | 2026-08-04 | $998.43M | $242.68M | $237.96M | $2.96 |
| 10-K | 2025-12-31 | 2026-02-20 | $4.30B | $1.06B | $1.18B | $13.08 |
| 10-K | 2024-12-31 | 2026-02-20 | $3.90B | $887.87M | $929.00M | $10.67 |
| 10-K | 2023-12-31 | 2026-02-20 | $3.66B | $845.04M | $906.51M | $10.06 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Idexx Laboratories (IDXX) valuation multiples, momentum factors, and point-in-time filing conventions.
How should IDXX's current valuation multiple be interpreted? ↓
IDXX trades at a trailing P/E of 32.8x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are IDXX's key momentum and technical factor indicators? ↓
As of the latest close, IDXX shows a 1-month return of +9.15%, 3-month return of +0.75%, and 12-month return of -11.58%, with a 14-day RSI of 64.8. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for IDXX? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can IDXX be incorporated into systematic factor models? ↓
IDXX can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.